Trademark: 97932065
Word
GEXTRAVIX
Status
Pending
Status Code
686
Status Date
Tuesday, March 12, 2024
Serial Number
97932065
Mark Type
4000
Filing Date
Thursday, May 11, 2023
Published for Opposition
Tuesday, March 12, 2024

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Trademark Events
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2024
Published For Opposition
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 6, 2024
Approved For Pub - Principal Register
Feb 5, 2024
Assigned To Examiner
May 16, 2023
New Application Office Supplied Data Entered
May 15, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24